Keyphrases
Prognostic Biomarker
100%
Scattering Intensity
100%
Intensity Estimation
100%
Dark-field Microscope
100%
Limit of Detection
50%
Serum Samples
50%
Noble Metal Nanoparticles
50%
Clinical Application
50%
Sample Pretreatment
50%
Enzyme-linked Immunosorbent Assay (ELISA)
50%
Assay Kit
50%
Silver Nanoparticles
50%
Primary Antibody
50%
Disease Screening
50%
Prostate-specific Antigen
50%
Alpha-fetoprotein
50%
Carcinoembryonic Antigen
50%
Gold Nanoparticles(AuNPs)
50%
Linear Dynamic Range
50%
Signal Amplification
50%
Intensity Change
50%
Secondary Antibody
50%
Capture Probe
50%
Measurement Method
50%
Plasmon Coupling
50%
Enhanced Scattering
50%
Immunocomplex
50%
Clinical Assay
50%
Single Particle Scattering
50%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Malignant Neoplasm
100%
Diseases
50%
Enzyme-Linked Immunosorbent Assay
50%
Gold Nanoparticle
50%
Metal Nanoparticle
50%
Silver Nanoparticle
50%
Blood Group A Antigen
50%
Prostate Specific Antigen
50%
Alpha Fetoprotein
50%
Carcinoembryonic Antigen
50%
Material Science
Metal Nanoparticle
100%
Surface (Surface Science)
100%
Gold Nanoparticles
100%
Gold Nanoparticle
100%
Silver Nanoparticle
100%
Silver Nanoparticle
100%
Chemistry
Biological Marker
100%
Gold Nanoparticle
50%
Noble Metal
50%
Silver Nanoparticle
50%
Metal Nanoparticle
50%
Enzyme-Linked Immunosorbent Assay
50%
Measurement Method
50%